Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2)

Peer Review reports

Original Submission
18 Mar 2021	Submitted	Original manuscript
27 May 2021	Reviewed	Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
25 Aug 2021	Reviewed	Reviewer Report - Jack Grierson
24 Sep 2021	Author responded	Author comments - Jack Knorr
Resubmission - Version 2
24 Sep 2021	Submitted	Manuscript version 2
Publishing
29 Sep 2021	Editorially accepted
21 Oct 2021	Article published	10.1186/s13063-021-05699-3

Back to article page